From Bench to Bedside: New Frontiers in Multiple Myeloma
How the latest clinical therapies are helping patients and laboratory research informing future treatments.
Progress Against Cancer
How the latest clinical therapies are helping patients and laboratory research informing future treatments.
A study found women in California were more likely to have cervical cancer diagnoses at a later stage after age 65.
Immunotherapy before surgery is proving to be an effective treatment against melanoma.
Therapeutic antibodies carry ‘payloads’ to destroy cancer cells.
Neurologist David Schiff discusses the significance of new evidence-based guidance on how to treat brain metastases from solid tumors.
Cardiovascular mortality rates for survivors of early-stage Hodgkin lymphoma outpace cancer-related mortality.
Technology could help detect lymphedema earlier.
Scientists look to decode the role of intestinal bacteria in our responses to immunotherapy.
Cancer treatment is a double-edged sword. Intense or multi-pronged treatment may lead to better killing of tumor cells, but it can often cause debilitating side effects. Is it possible to reduce the intensity of...
The new AKT inhibitor doubled progression-free survival when added to treatment with Faslodex.
AACR Fellow Lewis C. Cantley, PhD, leads a national effort targeting triple-negative breast cancer and ovarian cancer with a novel drug combination.
Learn More